Omega 3 fatty acids for the treatment of dementia and cognitive impairment
Dionisi , F. and Calder, P. C. (2011) Omega 3 fatty acids for the treatment of dementia and cognitive impairment. Cochrane Database of Systematic Reviews, (2) (doi:10.1002/14651858.CD009002).
Full text not available from this repository.
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the effect of omega 3 FA supplementation on cognitive functions in patients with dementia or mild cognitive impairment.
To assess the effect of omega 3 FA on global disease severity, neuropsychiatric symptoms, quality of life and performance of activities of daily living (ADLs) and to assess the safety and acceptability of omega 3 FA supplementation in patients with dementia and mild cognitive impairment
|Digital Object Identifier (DOI):||doi:10.1002/14651858.CD009002|
|Subjects:||Q Science > QD Chemistry
R Medicine > R Medicine (General)
|Divisions :||Faculty of Medicine > Human Development and Health
|Accepted Date and Publication Date:||
|Date Deposited:||20 Apr 2012 15:43|
|Last Modified:||31 Mar 2016 14:26|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)